These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7106088)

  • 1. Bioavailability of phenylbutazone preparations in the horse.
    Rose RJ; Kohnke JR; Baggot JD
    Equine Vet J; 1982 Jul; 14(3):234-7. PubMed ID: 7106088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on a new paste preparation of phenylbutazone.
    Snow DH; Douglas TA
    Vet Rec; 1983 Jun; 112(26):602-7. PubMed ID: 6879988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of phenylbutazone in the horse.
    Smith PB; Caldwell J; Smith RL; Horner MW; Moss MS
    Xenobiotica; 1987 Apr; 17(4):435-43. PubMed ID: 3604253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse.
    Sullivan M; Snow DH
    Vet Rec; 1982 Jun; 110(24):554-8. PubMed ID: 7112870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies.
    Maitho TE; Lees P; Taylor JB
    J Vet Pharmacol Ther; 1986 Mar; 9(1):26-39. PubMed ID: 3701913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylbutazone in the horse: a review.
    Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urine levels of phenylbutazone in the horse.
    Piperno E; Ellis DJ; Getty SM; Brody TM
    J Am Vet Med Assoc; 1968 Jul; 153(2):195-8. PubMed ID: 5655055
    [No Abstract]   [Full Text] [Related]  

  • 11. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of feeding on the fate of orally administered phenylbutazone, trimethoprim and sulphadiazine in the horse.
    Bogan JA; Galbraith A; Baxter P; Ali NM; Marriner SE
    Vet Rec; 1984 Dec; 115(23):599-600. PubMed ID: 6523691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylbutazone in the horse.
    Lees P; Maitho E; Taylor JB
    Vet Rec; 1982 Jun; 110(26):617. PubMed ID: 7123814
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses.
    Jaraiz V; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    J Vet Pharmacol Ther; 1999 Aug; 22(4):247-54. PubMed ID: 10499236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.